ucsf logobch logo

Eva C. Ihle, MD, PhD

Psychiatry • Child and Adolescent Psychiatry
Portrait of Eva C. Ihle
Portrait of Eva C. Ihle
ucsf logobch logo

Eva C. Ihle, MD, PhD

Psychiatry • Child and Adolescent Psychiatry

On this page

About me

Dr. Eva C. Ihle is a neuroscientist and psychiatrist who cares for children, adolescents and adults.

Ihle serves as interim medical director of the Division of Infant, Child and Adolescent Psychiatry at Zuckerberg San Francisco General Hospital and Trauma Center. She also directs the hospital’s program to enhance access to psychiatric care for underserved populations by partnering with primary care clinics.

In her research, Ihle has studied social behaviors in songbirds and a mouse model for autism. She also has examined the mechanisms that support health and well-being in individuals under stress.

Ihle earned her medical degree and a doctorate in neurobiology in the University of Chicago Medical Scientist Training Program. At UCSF, she completed a residency in general adult psychiatry, a fellowship in child and adolescent psychiatry, and a postdoctoral fellowship in the lab of Allison Doupe, investigating the biochemistry of social context.

Education & training

Board certification

  • Child & Adolescent Psychiatry, American Board of Psychiatry and Neurology
  • Psychiatry, American Board of Psychiatry and Neurology

Fellowship

  • Child/Adolescent Psychiatry, UCSF Graduate Medical Education

Residency

  • Psychiatry, UCSF Graduate Medical Education

Internship

  • Psychiatry, UCSF Graduate Medical Education

Degree

  • MD, University of Chicago Pritzker School of Medicine

My expertise

  • Specialties
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.

For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.